Biopharmaceutical research and development is uncovering new insights into how we view, understand and treat cancer, helping to transform a terrifying diagnosis into a healthier and longer life for patients.

Survival is increasing dramatically for many forms of cancer: since 1975, 5-year survival rates went up 21% for breast cancer; 50% for prostate cancer; 36% for colon cancer; 54% for lung cancer.

The path to creating life-saving treatments is an extremely long, labor-intensive effort that involves major investment. Each new cancer treatment, whether it extends a life by six months or cures the disease, reflects how innovation leads to improved patient outcomes.